Literature DB >> 11986983

Molecular abnormalities in the major psychiatric illnesses: Classification and Regression Tree (CRT) analysis of post-mortem prefrontal markers.

M B Knable1, B M Barci, J J Bartko, M J Webster, E F Torrey.   

Abstract

Post-mortem specimens from the Stanley Foundation Neuropathology Consortium, which contains matched samples from patients with schizophrenia, bipolar disorder, non-psychotic depression and normal controls (n = 15 per group), have been distributed to many research groups around the world. This paper provides a summary of abnormal markers found in prefrontal cortical areas from this collection between 1997 and 2001. With parametric analyses of variance of 102 separate data sets, 14 markers were abnormal in at least one disease. The markers pertained to a variety of neural systems and processes including neuronal plasticity, neurotransmission, signal transduction, inhibitory interneuron function and glial cells. The data sets were also examined using the non-parametric Classification and Regression Tree (CRT) technique for the four diagnostic groups and in pair-wise combinations. In contrast to the results obtained with analyses of variance, the CRT method identified a smaller set of nine markers that contributed maximally to the diagnostic classifications. Three of the nine markers observed with CRT overlapped with the ANOVA results. Six of the nine markers observed with the CRT technique pertained to aspects of glutamatergic, GABA-ergic, and dopaminergic neurotransmission.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11986983     DOI: 10.1038/sj.mp.4001034

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  24 in total

1.  Pyramidal cell selective ablation of N-methyl-D-aspartate receptor 1 causes increase in cellular and network excitability.

Authors:  Valerie M Tatard-Leitman; Catherine R Jutzeler; Jimmy Suh; John A Saunders; Eddie N Billingslea; Susumu Morita; Rachel White; Robert E Featherstone; Rabindranath Ray; Pavel I Ortinski; Anamika Banerjee; Michael J Gandal; Robert Lin; Anamaria Alexandrescu; Yuling Liang; Raquel E Gur; Karin E Borgmann-Winter; Gregory C Carlson; Chang-Gyu Hahn; Steven J Siegel
Journal:  Biol Psychiatry       Date:  2014-07-18       Impact factor: 13.382

2.  Covariate adjusted classification trees.

Authors:  Josephine K Asafu-Adjei; Allan R Sampson
Journal:  Biostatistics       Date:  2018-01-01       Impact factor: 5.899

3.  Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex.

Authors:  Nikolaus Michael; Andreas Erfurth; Patricia Ohrmann; Michael Gössling; Volker Arolt; Walter Heindel; Bettina Pfleiderer
Journal:  Psychopharmacology (Berl)       Date:  2003-04-09       Impact factor: 4.530

Review 4.  Neurodevelopment, GABA system dysfunction, and schizophrenia.

Authors:  Martin J Schmidt; Karoly Mirnics
Journal:  Neuropsychopharmacology       Date:  2014-04-24       Impact factor: 7.853

Review 5.  The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia.

Authors:  Samuel M Cohen; Richard W Tsien; Donald C Goff; Michael M Halassa
Journal:  Schizophr Res       Date:  2015-01-09       Impact factor: 4.939

Review 6.  Hippocampal GABAergic Inhibitory Interneurons.

Authors:  Kenneth A Pelkey; Ramesh Chittajallu; Michael T Craig; Ludovic Tricoire; Jason C Wester; Chris J McBain
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

7.  Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats.

Authors:  Nurith Amitai; Ronald Kuczenski; M Margarita Behrens; Athina Markou
Journal:  Neuropharmacology       Date:  2011-01-14       Impact factor: 5.250

8.  Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse.

Authors:  Thomas Wobrock; Alkomiet Hasan; Berend Malchow; Claus Wolff-Menzler; Birgit Guse; Nicolas Lang; Thomas Schneider-Axmann; Ullrich K H Ecker; Peter Falkai
Journal:  Psychopharmacology (Berl)       Date:  2009-12-09       Impact factor: 4.530

Review 9.  Target identification for CNS diseases by transcriptional profiling.

Authors:  C Anthony Altar; Marquis P Vawter; Stephen D Ginsberg
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

Review 10.  Synapse-specific contributions in the cortical pathology of schizophrenia.

Authors:  Saurav Seshadri; Mariela Zeledon; Akira Sawa
Journal:  Neurobiol Dis       Date:  2013-01-18       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.